Halal Pharmaceutical Standards Increase Malaysia’s Access to Global Halal Pharmaceutical Market

Speaking at a webinar on “Embracing a Halal Pharmaceutical Eco-System” in Malaysia on the 28th of July 2020, Duopharma Biotech Group Managing Director, Leonard Ariff Abdul Shatar, stated that Malaysia’s global leadership in the Halal certification front has paved the way for domestic pharmaceutical manufacturers to successfully enter the global halal pharmaceutical market.

According to Leonard Ariff, Malaysia’s MS2424:2012 Halal Pharmaceutical Standard, which has now evolved into the MS2424:2019, has significantly increased the scope of Halal certification. The standard allows the industry to address an increasing demand in biologics, as well as the quest for Halal vaccines.

Become IslamicMarkets.com member

We provide tools that help professionals and institutions steer the global
Islamic economy, unlocking commercial opportunities.

Get more with

• An ecosystem of 500,000+ users
• 50,000+ publications and resources
• Exclusive newsletters and breakthrough stories
• Over 300 industry-led learning modules
• See all benefits >>

Create FREE account or Log in

See all Subscription options